Propylphenidine

Chemical compound From Wikipedia, the free encyclopedia

Propylphenidine is a compound which has been sold as a designer drug, first identified in Australia in 2023. It is unclear what kind of activity it has, as it is claimed to be a stimulant in a patent along with related compounds such as phenylpropylaminopentane, but other structurally similar compounds such as ephenidine and isophenidine are dissociative anesthetic drugs, so it may produce either kind of activity or perhaps a mixture of both.[1][2][3]

Legal status
  • AU: S9 (Prohibited substance)
Quick facts Legal status, Identifiers ...
Propylphenidine
Legal status
Legal status
  • AU: S9 (Prohibited substance)
Identifiers
  • N-(1,2-diphenylethyl)propan-1-amine
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC17H21N
Molar mass239.362 g·mol−1
3D model (JSmol)
  • CCCNC(CC1=CC=CC=C1)C2=CC=CC=C2
  • InChI=1S/C17H21N/c1-2-13-18-17(16-11-7-4-8-12-16)14-15-9-5-3-6-10-15/h3-12,17-18H,2,13-14H2,1H3
  • Key:QDJKYFSVYJISOP-UHFFFAOYSA-N
Close

In Australia, the Therapeutic Goods Administration decided to include propylphenidine as a Prohibited substance (Schedule 9) within the Standard for the Uniform Scheduling of Medicines and Poisons alongside four other phenidine analogs on 1 October 2024.[4]

See also

References

Related Articles

Wikiwand AI